HEADER TRANSPORT PROTEIN 17-APR-08 3CV0 TITLE STRUCTURE OF PEROXISOMAL TARGETING SIGNAL 1 (PTS1) BINDING DOMAIN OF TITLE 2 TRYPANOSOMA BRUCEI PEROXIN 5 (TBPEX5)COMPLEXED TO T. BRUCEI TITLE 3 PHOSPHOGLUCOISOMERASE (PGI) PTS1 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME TARGETING SIGNAL 1 RECEPTOR PEX5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 332-655; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: T. BRUCEI PGI PTS1 PEPTIDE AC-FNELSHL; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI; SOURCE 3 GENE: PEX5; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PSKB3; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS TPR MOTIFS, TPR PROTEIN, PEROXIN 5, PEX5, PTS1 BINDING DOMAIN, KEYWDS 2 PROTEIN-PEPTIDE COMPLEX, RECEPTOR, TPR REPEAT, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.SAMPATHKUMAR,C.ROACH,P.A.M.MICHELS,W.G.J.HOL REVDAT 7 03-APR-24 3CV0 1 REMARK REVDAT 6 21-FEB-24 3CV0 1 REMARK REVDAT 5 20-OCT-21 3CV0 1 REMARK SEQADV REVDAT 4 24-JAN-18 3CV0 1 AUTHOR REVDAT 3 24-FEB-09 3CV0 1 VERSN REVDAT 2 09-SEP-08 3CV0 1 JRNL REVDAT 1 24-JUN-08 3CV0 0 JRNL AUTH P.SAMPATHKUMAR,C.ROACH,P.A.MICHELS,W.G.HOL JRNL TITL STRUCTURAL INSIGHTS INTO THE RECOGNITION OF PEROXISOMAL JRNL TITL 2 TARGETING SIGNAL 1 BY TRYPANOSOMA BRUCEI PEROXIN 5. JRNL REF J.MOL.BIOL. V. 381 867 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18598704 JRNL DOI 10.1016/J.JMB.2008.05.089 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 19869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1013 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1091 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.3180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2377 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 116 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : 0.01000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.213 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.178 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.642 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2506 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1656 ; 0.016 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3393 ; 1.327 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4024 ; 0.989 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 315 ; 5.734 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 129 ;39.636 ;24.806 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 390 ;14.083 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;15.533 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 370 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2835 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 497 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 588 ; 0.220 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1713 ; 0.185 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1209 ; 0.177 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1224 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 100 ; 0.179 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 32 ; 0.263 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 55 ; 0.261 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 17 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1983 ; 1.010 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 615 ; 0.184 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2458 ; 1.155 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1107 ; 2.052 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 928 ; 2.942 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CV0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047243. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC VARIMAX REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19875 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 43.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 3.490 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10500 REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.33 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38000 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1FHC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.3M POTASSIUM ACETATE, 0.1M SODIUM REMARK 280 CITRATE MONOHYDRATE, PH 4.8, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.20200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT OF PROTEIN PEX5 IS MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 454 REMARK 465 SER A 455 REMARK 465 VAL A 456 REMARK 465 ASN A 457 REMARK 465 LEU A 458 REMARK 465 GLN A 459 REMARK 465 ALA A 460 REMARK 465 ASP A 461 REMARK 465 VAL A 462 REMARK 465 ASP A 463 REMARK 465 ILE A 464 REMARK 465 ASP A 465 REMARK 465 ASP A 466 REMARK 465 LEU A 467 REMARK 465 ASN A 468 REMARK 465 VAL A 469 REMARK 465 GLN A 470 REMARK 465 SER A 471 REMARK 465 GLU A 472 REMARK 465 ASP A 473 REMARK 465 PRO A 604 REMARK 465 THR A 605 REMARK 465 GLY A 606 REMARK 465 GLU A 607 REMARK 465 ALA A 608 REMARK 465 LEU A 654 REMARK 465 LEU A 655 REMARK 465 PHE B 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 330 CG ND1 CD2 CE1 NE2 REMARK 470 MET A 331 CG SD CE REMARK 470 LYS A 361 CG CD CE NZ REMARK 470 GLN A 452 CG CD OE1 NE2 REMARK 470 ARG A 483 CG CD NE CZ NH1 NH2 REMARK 470 SER A 609 OG REMARK 470 ARG A 610 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 611 CG CD OE1 OE2 REMARK 470 GLU A 634 CG CD OE1 OE2 REMARK 470 ASN B 2 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 524 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 335 10.77 -156.38 REMARK 500 ALA A 478 66.43 -161.48 REMARK 500 ARG A 610 -80.96 -93.67 REMARK 500 GLU A 611 -68.34 62.68 REMARK 500 SER A 652 -103.73 40.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 9 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 10 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 12 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CVL RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH T.BRUCEI PHOSPHOFRUCTO KINASE (TBPFK) REMARK 900 PTS1 PEPTIDE REMARK 900 RELATED ID: 3CVN RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED TO T. BRUCEI GLYCERALDEHYDE-3-PHOSPHATE REMARK 900 DEHYDROGENASE (TBGAPDH) PTS1 PEPTIDE REMARK 900 RELATED ID: 3CVP RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEX WITH PTS1 PEPTIDE (10-SKL WITH THE SEQUENCE REMARK 900 ACGTLSNRASKL) REMARK 900 RELATED ID: 3CVQ RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEX WITH PTS1 PEPTIDE (7-SKL WITH THE SEQUENCE REMARK 900 SNRWSKL) REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACE IS COVALENTLY BONDED TO PHE IN CHAIN B, BUT IS NOT OBSERVED IN REMARK 999 ELECTRON DENSITY MAP DBREF 3CV0 A 332 655 UNP Q9U7C3 Q9U7C3_9TRYP 332 655 DBREF 3CV0 B 1 7 UNP P13377 G6PI_TRYBB 601 607 SEQADV 3CV0 GLY A 329 UNP Q9U7C3 EXPRESSION TAG SEQADV 3CV0 HIS A 330 UNP Q9U7C3 EXPRESSION TAG SEQADV 3CV0 MET A 331 UNP Q9U7C3 EXPRESSION TAG SEQADV 3CV0 ALA A 378 UNP Q9U7C3 LYS 378 ENGINEERED MUTATION SEQADV 3CV0 ALA A 379 UNP Q9U7C3 GLU 379 ENGINEERED MUTATION SEQRES 1 A 327 GLY HIS MET LEU GLN ASN ASN THR ASP TYR PRO PHE GLU SEQRES 2 A 327 ALA ASN ASN PRO TYR MET TYR HIS GLU ASN PRO MET GLU SEQRES 3 A 327 GLU GLY LEU SER MET LEU LYS LEU ALA ASN LEU ALA GLU SEQRES 4 A 327 ALA ALA LEU ALA PHE GLU ALA VAL CYS GLN ALA ALA PRO SEQRES 5 A 327 GLU ARG GLU GLU ALA TRP ARG SER LEU GLY LEU THR GLN SEQRES 6 A 327 ALA GLU ASN GLU LYS ASP GLY LEU ALA ILE ILE ALA LEU SEQRES 7 A 327 ASN HIS ALA ARG MET LEU ASP PRO LYS ASP ILE ALA VAL SEQRES 8 A 327 HIS ALA ALA LEU ALA VAL SER HIS THR ASN GLU HIS ASN SEQRES 9 A 327 ALA ASN ALA ALA LEU ALA SER LEU ARG ALA TRP LEU LEU SEQRES 10 A 327 SER GLN PRO GLN TYR GLU GLN LEU GLY SER VAL ASN LEU SEQRES 11 A 327 GLN ALA ASP VAL ASP ILE ASP ASP LEU ASN VAL GLN SER SEQRES 12 A 327 GLU ASP PHE PHE PHE ALA ALA PRO ASN GLU TYR ARG GLU SEQRES 13 A 327 CYS ARG THR LEU LEU HIS ALA ALA LEU GLU MET ASN PRO SEQRES 14 A 327 ASN ASP ALA GLN LEU HIS ALA SER LEU GLY VAL LEU TYR SEQRES 15 A 327 ASN LEU SER ASN ASN TYR ASP SER ALA ALA ALA ASN LEU SEQRES 16 A 327 ARG ARG ALA VAL GLU LEU ARG PRO ASP ASP ALA GLN LEU SEQRES 17 A 327 TRP ASN LYS LEU GLY ALA THR LEU ALA ASN GLY ASN ARG SEQRES 18 A 327 PRO GLN GLU ALA LEU ASP ALA TYR ASN ARG ALA LEU ASP SEQRES 19 A 327 ILE ASN PRO GLY TYR VAL ARG VAL MET TYR ASN MET ALA SEQRES 20 A 327 VAL SER TYR SER ASN MET SER GLN TYR ASP LEU ALA ALA SEQRES 21 A 327 LYS GLN LEU VAL ARG ALA ILE TYR MET GLN VAL GLY GLY SEQRES 22 A 327 THR THR PRO THR GLY GLU ALA SER ARG GLU ALA THR ARG SEQRES 23 A 327 SER MET TRP ASP PHE PHE ARG MET LEU LEU ASN VAL MET SEQRES 24 A 327 ASN ARG PRO ASP LEU VAL GLU LEU THR TYR ALA GLN ASN SEQRES 25 A 327 VAL GLU PRO PHE ALA LYS GLU PHE GLY LEU GLN SER MET SEQRES 26 A 327 LEU LEU SEQRES 1 B 7 PHE ASN GLU LEU SER HIS LEU HET EDO A 1 4 HET EDO A 2 4 HET EDO A 3 4 HET EDO A 4 4 HET EDO A 5 4 HET EDO A 6 4 HET EDO A 7 4 HET EDO A 8 4 HET EDO A 9 4 HET EDO A 10 4 HET EDO A 11 4 HET EDO A 12 4 HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 12(C2 H6 O2) FORMUL 15 HOH *116(H2 O) HELIX 1 1 ASN A 344 HIS A 349 5 6 HELIX 2 2 ASN A 351 LEU A 362 1 12 HELIX 3 3 ASN A 364 ALA A 379 1 16 HELIX 4 4 ARG A 382 ASN A 396 1 15 HELIX 5 5 LYS A 398 ASP A 413 1 16 HELIX 6 6 ASP A 416 GLU A 430 1 15 HELIX 7 7 ASN A 432 SER A 446 1 15 HELIX 8 8 ALA A 478 ASN A 496 1 19 HELIX 9 9 ASP A 499 SER A 513 1 15 HELIX 10 10 ASN A 515 ARG A 530 1 16 HELIX 11 11 ASP A 533 GLY A 547 1 15 HELIX 12 12 ARG A 549 ASN A 564 1 16 HELIX 13 13 TYR A 567 MET A 581 1 15 HELIX 14 14 GLN A 583 VAL A 599 1 17 HELIX 15 15 GLU A 611 MET A 627 1 17 HELIX 16 16 ARG A 629 TYR A 637 1 9 HELIX 17 17 VAL A 641 PHE A 648 1 8 SITE 1 AC1 1 ASN A 625 SITE 1 AC2 4 ARG A 549 PRO A 550 GLN A 551 GLU A 552 SITE 1 AC3 4 GLU A 350 ASN A 351 GLU A 354 GLU A 355 SITE 1 AC4 6 ARG A 410 HIS A 420 LEU A 423 ALA A 435 SITE 2 AC4 6 SER A 439 ALA A 442 SITE 1 AC5 5 ALA A 394 ASN A 538 TYR A 567 ARG A 569 SITE 2 AC5 5 LEU B 7 SITE 1 AC6 2 GLN A 535 LYS A 539 SITE 1 AC7 3 ASN A 511 ASN A 514 TYR A 516 SITE 1 AC8 3 ARG A 621 ASN A 625 TYR A 637 SITE 1 AC9 4 GLN A 501 ALA A 504 SER A 505 LYS A 539 SITE 1 BC1 2 GLY A 329 GLU A 381 SITE 1 BC2 3 LEU A 360 LEU A 391 GLU A 395 CRYST1 45.405 66.404 52.117 90.00 104.47 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022024 0.000000 0.005683 0.00000 SCALE2 0.000000 0.015059 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019816 0.00000